- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.67 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
MG.2: 4 residues within 4Å:- Chain A: D.440, N.467, G.469
- Ligands: TPP.1
3 PLIP interactions:2 interactions with chain A, 1 Ligand-Water interactions- Metal complexes: A:D.440, A:G.469, H2O.11
MG.19: 4 residues within 4Å:- Chain B: D.440, N.467, G.469
- Ligands: TPP.18
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:D.440, B:G.469, H2O.30
MG.40: 4 residues within 4Å:- Chain C: D.440, N.467, G.469
- Ligands: TPP.39
3 PLIP interactions:2 interactions with chain C, 1 Ligand-Water interactions- Metal complexes: C:D.440, C:G.469, H2O.49
MG.57: 4 residues within 4Å:- Chain D: D.440, N.467, G.469
- Ligands: TPP.56
3 PLIP interactions:2 interactions with chain D, 1 Ligand-Water interactions- Metal complexes: D:D.440, D:G.469, H2O.69
- 32 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 4 residues within 4Å:- Chain A: I.484, K.485, N.486
- Chain C: S.504
Ligand excluded by PLIPSO4.4: 4 residues within 4Å:- Chain A: D.234, G.237, H.256, K.337
Ligand excluded by PLIPSO4.5: 5 residues within 4Å:- Chain A: E.308, P.309, R.310, S.311, R.318
Ligand excluded by PLIPSO4.6: 8 residues within 4Å:- Chain A: H.106, A.107, D.120, Y.121, H.122
- Chain D: H.122, Y.139
- Ligands: SO4.61
Ligand excluded by PLIPSO4.7: 3 residues within 4Å:- Chain A: K.153, R.157
- Chain B: R.310
Ligand excluded by PLIPSO4.8: 4 residues within 4Å:- Chain A: T.379, N.381, T.382, R.433
Ligand excluded by PLIPSO4.20: 3 residues within 4Å:- Chain B: Q.15, P.180, A.181
Ligand excluded by PLIPSO4.21: 5 residues within 4Å:- Chain B: S.504
- Chain D: I.484, K.485, N.486
- Ligands: EDO.37
Ligand excluded by PLIPSO4.22: 4 residues within 4Å:- Chain B: D.234, G.237, H.256, K.337
Ligand excluded by PLIPSO4.23: 7 residues within 4Å:- Chain B: H.106, A.107, T.119, D.120, Y.121, H.122
- Ligands: SO4.44
Ligand excluded by PLIPSO4.24: 4 residues within 4Å:- Chain A: E.188, R.310
- Chain B: K.153, R.157
Ligand excluded by PLIPSO4.25: 4 residues within 4Å:- Chain B: E.308, P.309, R.310, S.311
Ligand excluded by PLIPSO4.26: 4 residues within 4Å:- Chain B: T.379, N.381, T.382, R.433
Ligand excluded by PLIPSO4.27: 2 residues within 4Å:- Chain B: E.136, H.150
Ligand excluded by PLIPSO4.28: 7 residues within 4Å:- Chain B: T.260, V.265, Y.267, F.393, Q.396, R.397, E.547
Ligand excluded by PLIPSO4.29: 4 residues within 4Å:- Chain B: P.268, G.269, K.272, A.350
Ligand excluded by PLIPSO4.41: 4 residues within 4Å:- Chain A: S.504
- Chain C: I.484, K.485, N.486
Ligand excluded by PLIPSO4.42: 4 residues within 4Å:- Chain C: D.234, G.237, H.256, K.337
Ligand excluded by PLIPSO4.43: 5 residues within 4Å:- Chain C: E.308, P.309, R.310, S.311, R.318
Ligand excluded by PLIPSO4.44: 8 residues within 4Å:- Chain B: H.122, Y.139
- Chain C: H.106, A.107, D.120, Y.121, H.122
- Ligands: SO4.23
Ligand excluded by PLIPSO4.45: 3 residues within 4Å:- Chain C: K.153, R.157
- Chain D: R.310
Ligand excluded by PLIPSO4.46: 4 residues within 4Å:- Chain C: T.379, N.381, T.382, R.433
Ligand excluded by PLIPSO4.58: 3 residues within 4Å:- Chain D: Q.15, P.180, A.181
Ligand excluded by PLIPSO4.59: 5 residues within 4Å:- Chain B: I.484, K.485, N.486
- Chain D: S.504
- Ligands: EDO.75
Ligand excluded by PLIPSO4.60: 4 residues within 4Å:- Chain D: D.234, G.237, H.256, K.337
Ligand excluded by PLIPSO4.61: 7 residues within 4Å:- Chain D: H.106, A.107, T.119, D.120, Y.121, H.122
- Ligands: SO4.6
Ligand excluded by PLIPSO4.62: 4 residues within 4Å:- Chain C: E.188, R.310
- Chain D: K.153, R.157
Ligand excluded by PLIPSO4.63: 4 residues within 4Å:- Chain D: E.308, P.309, R.310, S.311
Ligand excluded by PLIPSO4.64: 4 residues within 4Å:- Chain D: T.379, N.381, T.382, R.433
Ligand excluded by PLIPSO4.65: 2 residues within 4Å:- Chain D: E.136, H.150
Ligand excluded by PLIPSO4.66: 7 residues within 4Å:- Chain D: T.260, V.265, Y.267, F.393, Q.396, R.397, E.547
Ligand excluded by PLIPSO4.67: 4 residues within 4Å:- Chain D: P.268, G.269, K.272, A.350
Ligand excluded by PLIP- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.9: 4 residues within 4Å:- Chain A: E.192, L.195, N.196, R.330
Ligand excluded by PLIPEDO.10: 5 residues within 4Å:- Chain A: I.16, K.64, G.65, A.66, L.156
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: E.252, Y.257, I.258, G.259, Y.267, K.399
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain A: R.157, K.159, K.219, A.222, P.309, R.310
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain A: K.153, L.156, R.157, L.184, F.185, N.186, D.187
Ligand excluded by PLIPEDO.14: 3 residues within 4Å:- Chain A: S.190, D.191, E.192
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: R.157, D.187, E.188
- Chain B: R.157, D.187, E.188
Ligand excluded by PLIPEDO.16: 1 residues within 4Å:- Chain C: R.455
Ligand excluded by PLIPEDO.17: 8 residues within 4Å:- Chain A: F.205, P.301, K.302, L.304, V.305, V.314, N.315, G.316
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: E.252, Y.257, I.258, Y.267, K.399
Ligand excluded by PLIPEDO.31: 6 residues within 4Å:- Chain B: S.248, P.251, P.401, N.402, G.403, A.404
Ligand excluded by PLIPEDO.32: 8 residues within 4Å:- Chain B: F.205, P.301, K.302, L.304, V.305, V.314, N.315, G.316
Ligand excluded by PLIPEDO.33: 5 residues within 4Å:- Chain B: E.158, K.159, A.222, P.309, R.310
Ligand excluded by PLIPEDO.34: 6 residues within 4Å:- Chain B: P.141, E.142, P.145, P.174, C.175, A.176
Ligand excluded by PLIPEDO.35: 1 residues within 4Å:- Chain B: N.402
Ligand excluded by PLIPEDO.36: 6 residues within 4Å:- Chain B: L.116, G.117, K.118
- Chain D: Y.88, K.160, K.219
Ligand excluded by PLIPEDO.37: 6 residues within 4Å:- Chain B: R.455, K.457, S.504, G.505
- Chain D: K.485
- Ligands: SO4.21
Ligand excluded by PLIPEDO.38: 5 residues within 4Å:- Chain B: M.1, D.38, N.39, K.40, N.41
Ligand excluded by PLIPEDO.47: 4 residues within 4Å:- Chain C: E.192, L.195, N.196, R.330
Ligand excluded by PLIPEDO.48: 5 residues within 4Å:- Chain C: I.16, K.64, G.65, A.66, L.156
Ligand excluded by PLIPEDO.49: 6 residues within 4Å:- Chain C: E.252, Y.257, I.258, G.259, Y.267, K.399
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain C: R.157, K.159, K.219, A.222, P.309, R.310
Ligand excluded by PLIPEDO.51: 7 residues within 4Å:- Chain C: K.153, L.156, R.157, L.184, F.185, N.186, D.187
Ligand excluded by PLIPEDO.52: 3 residues within 4Å:- Chain C: S.190, D.191, E.192
Ligand excluded by PLIPEDO.53: 6 residues within 4Å:- Chain C: R.157, D.187, E.188
- Chain D: R.157, D.187, E.188
Ligand excluded by PLIPEDO.54: 1 residues within 4Å:- Chain A: R.455
Ligand excluded by PLIPEDO.55: 8 residues within 4Å:- Chain C: F.205, P.301, K.302, L.304, V.305, V.314, N.315, G.316
Ligand excluded by PLIPEDO.68: 5 residues within 4Å:- Chain D: E.252, Y.257, I.258, Y.267, K.399
Ligand excluded by PLIPEDO.69: 6 residues within 4Å:- Chain D: S.248, P.251, P.401, N.402, G.403, A.404
Ligand excluded by PLIPEDO.70: 8 residues within 4Å:- Chain D: F.205, P.301, K.302, L.304, V.305, V.314, N.315, G.316
Ligand excluded by PLIPEDO.71: 5 residues within 4Å:- Chain D: E.158, K.159, A.222, P.309, R.310
Ligand excluded by PLIPEDO.72: 6 residues within 4Å:- Chain D: P.141, E.142, P.145, P.174, C.175, A.176
Ligand excluded by PLIPEDO.73: 1 residues within 4Å:- Chain D: N.402
Ligand excluded by PLIPEDO.74: 6 residues within 4Å:- Chain B: Y.88, K.160, K.219
- Chain D: L.116, G.117, K.118
Ligand excluded by PLIPEDO.75: 6 residues within 4Å:- Chain B: K.485
- Chain D: R.455, K.457, S.504, G.505
- Ligands: SO4.59
Ligand excluded by PLIPEDO.76: 5 residues within 4Å:- Chain D: M.1, D.38, N.39, K.40, N.41
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sammond, D.W. et al., An iterative computational design approach to increase the thermal endurance of a mesophilic enzyme. Biotechnol Biofuels (2018)
- Release Date
- 2017-10-18
- Peptides
- Pyruvate decarboxylase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.67 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x TPP: THIAMINE DIPHOSPHATE(Non-covalent)
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 32 x SO4: SULFATE ION(Non-functional Binders)
- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sammond, D.W. et al., An iterative computational design approach to increase the thermal endurance of a mesophilic enzyme. Biotechnol Biofuels (2018)
- Release Date
- 2017-10-18
- Peptides
- Pyruvate decarboxylase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B